Filtered By:
Source: Circulation

This page shows you your search results in order of date. This is page number 5.

Order by Relevance | Date

Total 925 results found since Jan 2013.

Eliminating Medication Copayments for Low-income Older Adults at High Cardiovascular Risk: A Randomized Controlled Trial
Conclusions: In low-income adults at high cardiovascular risk, eliminating copayments (average $35 a month) did not improve clinical outcomes or reduce healthcare costs, despite a modest improvement in adherence to medications.PMID:36871215 | DOI:10.1161/CIRCULATIONAHA.123.064188
Source: Circulation - March 5, 2023 Category: Cardiology Authors: David J T Campbell Chad Mitchell Brenda R Hemmelgarn Marcello Tonelli Peter Faris Jianguo Zhang Ross T Tsuyuki Jane Fletcher Flora Au Scott Klarenbach Derek V Exner Braden J Manns Interdisciplinary Chronic Disease Collaboration Source Type: research

Self-management Support Using Advertising Principles for Older Low Income Adults at High Cardiovascular Risk: a Randomized Controlled Trial
Conclusions: In low-income older adults, a tailored SMES program using advertising principles reduced the rate of clinical outcomes compared with usual care, though the mechanisms of improvement are unclear and further studies are required.PMID:36871212 | DOI:10.1161/CIRCULATIONAHA.123.064189
Source: Circulation - March 5, 2023 Category: Cardiology Authors: David J T Campbell Marcello Tonelli Brenda R Hemmelgarn Peter Faris Jianguo Zhang Flora Au Ross T Tsuyuki Chad Mitchell Raj Pannu Tavis Campbell Noah Ivers Jane Fletcher Derek V Exner Braden J Manns Interdisciplinary Chronic Disease Collaboration Source Type: research

Comparison of Unibody and Non-Unibody Endografts for Abdominal Aortic Aneurysm Repair in Medicare Beneficiaries: The SAFE-AAA Study
CONCLUSIONS: In the SAFE-AAA Study, unibody endografts failed to meet noninferiority compared with non-unibody endografts with respect to aortic reintervention, rupture, and mortality. These data support the urgency of instituting a prospective longitudinal surveillance program for monitoring safety events related to aortic stent grafts.PMID:36866664 | DOI:10.1161/CIRCULATIONAHA.122.062123
Source: Circulation - March 3, 2023 Category: Cardiology Authors: Eric A Secemsky Yang Song Tianyu Sun Carmen Gacchina Johnson Megan Gatski Li Wang Andrew Farb Robert E Lee Aurko Shaw Jiaman Xu Robert W Yeh Source Type: research

Correction to: Overestimation of Stroke Risk in Rheumatic Mitral Stenosis and the Implications for Oral Anticoagulation
Circulation. 2023 Feb 21;147(8):e623. doi: 10.1161/CIR.0000000000001130. Epub 2023 Feb 20.NO ABSTRACTPMID:36802887 | DOI:10.1161/CIR.0000000000001130
Source: Circulation - February 21, 2023 Category: Cardiology Source Type: research

Correction to: Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
Circulation. 2023 Feb 21;147(8):e622. doi: 10.1161/CIR.0000000000001137. Epub 2023 Feb 20.NO ABSTRACTPMID:36802886 | DOI:10.1161/CIR.0000000000001137
Source: Circulation - February 21, 2023 Category: Cardiology Source Type: research

Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial
CONCLUSIONS: The graded salutary relationship between efpeglenatide dose and cardiovascular outcomes suggests that titrating efpeglenatide and potentially other glucagon-like peptide-1 receptor agonists to high doses may maximize their cardiovascular and renal benefits.REGISTRATION: URL: https://www.CLINICALTRIALS: gov; Unique identifier: NCT03496298.PMID:36802715 | DOI:10.1161/CIRCULATIONAHA.122.063716
Source: Circulation - February 21, 2023 Category: Cardiology Authors: Hertzel C Gerstein Zhuoru Li Chinthanie Ramasundarahettige Seungjae Baek Kelley R H Branch Stefano Del Prato Carolyn S P Lam Renato D Lopes Richard Pratley Julio Rosenstock Naveed Sattar Source Type: research

Correction to: Overestimation of Stroke Risk in Rheumatic Mitral Stenosis and the Implications for Oral Anticoagulation
Circulation. 2023 Feb 21;147(8):e623. doi: 10.1161/CIR.0000000000001130. Epub 2023 Feb 20.NO ABSTRACTPMID:36802887 | DOI:10.1161/CIR.0000000000001130
Source: Circulation - February 21, 2023 Category: Cardiology Source Type: research

Correction to: Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
Circulation. 2023 Feb 21;147(8):e622. doi: 10.1161/CIR.0000000000001137. Epub 2023 Feb 20.NO ABSTRACTPMID:36802886 | DOI:10.1161/CIR.0000000000001137
Source: Circulation - February 21, 2023 Category: Cardiology Source Type: research

Correction to: Overestimation of Stroke Risk in Rheumatic Mitral Stenosis and the Implications for Oral Anticoagulation
Circulation. 2023 Feb 21;147(8):e623. doi: 10.1161/CIR.0000000000001130. Epub 2023 Feb 20.NO ABSTRACTPMID:36802887 | DOI:10.1161/CIR.0000000000001130
Source: Circulation - February 21, 2023 Category: Cardiology Source Type: research

Correction to: Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
Circulation. 2023 Feb 21;147(8):e622. doi: 10.1161/CIR.0000000000001137. Epub 2023 Feb 20.NO ABSTRACTPMID:36802886 | DOI:10.1161/CIR.0000000000001137
Source: Circulation - February 21, 2023 Category: Cardiology Source Type: research

Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial
CONCLUSIONS: The graded salutary relationship between efpeglenatide dose and cardiovascular outcomes suggests that titrating efpeglenatide and potentially other glucagon-like peptide-1 receptor agonists to high doses may maximize their cardiovascular and renal benefits.REGISTRATION: URL: https://www.CLINICALTRIALS: gov; Unique identifier: NCT03496298.PMID:36802715 | DOI:10.1161/CIRCULATIONAHA.122.063716
Source: Circulation - February 21, 2023 Category: Cardiology Authors: Hertzel C Gerstein Zhuoru Li Chinthanie Ramasundarahettige Seungjae Baek Kelley R H Branch Stefano Del Prato Carolyn S P Lam Renato D Lopes Richard Pratley Julio Rosenstock Naveed Sattar Source Type: research

Correction to: Overestimation of Stroke Risk in Rheumatic Mitral Stenosis and the Implications for Oral Anticoagulation
Circulation. 2023 Feb 21;147(8):e623. doi: 10.1161/CIR.0000000000001130. Epub 2023 Feb 20.NO ABSTRACTPMID:36802887 | DOI:10.1161/CIR.0000000000001130
Source: Circulation - February 21, 2023 Category: Cardiology Source Type: research

Correction to: Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
Circulation. 2023 Feb 21;147(8):e622. doi: 10.1161/CIR.0000000000001137. Epub 2023 Feb 20.NO ABSTRACTPMID:36802886 | DOI:10.1161/CIR.0000000000001137
Source: Circulation - February 21, 2023 Category: Cardiology Source Type: research

Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial
CONCLUSIONS: The graded salutary relationship between efpeglenatide dose and cardiovascular outcomes suggests that titrating efpeglenatide and potentially other glucagon-like peptide-1 receptor agonists to high doses may maximize their cardiovascular and renal benefits.REGISTRATION: URL: https://www.CLINICALTRIALS: gov; Unique identifier: NCT03496298.PMID:36802715 | DOI:10.1161/CIRCULATIONAHA.122.063716
Source: Circulation - February 21, 2023 Category: Cardiology Authors: Hertzel C Gerstein Zhuoru Li Chinthanie Ramasundarahettige Seungjae Baek Kelley R H Branch Stefano Del Prato Carolyn S P Lam Renato D Lopes Richard Pratley Julio Rosenstock Naveed Sattar Source Type: research